RxDoctor Payments Data

David Devellis, MD

Psychiatry · Chelsea, MINPI 1851616197

Payments from drug & device makers

$1,106in general payments, 2019–2025

Across 50 payments — averaging $22.12 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.)$333
  • Neurocrine Biosciences, Inc.$175
  • Axsome Therapeutics, Inc.$148
  • Otsuka America Pharmaceutical, Inc.$147
  • Alkermes, Inc.$71
  • Takeda Pharmaceuticals U.S.A., Inc.$65
  • plus $168 from 6 others

What the payments were for

  • Food & beverage$1,05996%
  • Education$474%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$1,106 in reported general payments places this provider in the 75th percentile of 1,166 psychiatry providers in Michigan.

See all psychiatry providers in Michigan

Medicare billing

Part B allowed, 2024
$13,561
Medicare patients
18
Services billed
105

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Bupropion XlBupropion Hcl73$1,969
Fluvoxamine Maleate20$1,482
Duloxetine Hcl56$1,136
Venlafaxine Hcl ErVenlafaxine Hcl31$930
Fluoxetine Hcl47$627
Dextroamphetamine-AmphetamineDextroamphetamine/Amphetamine35$560
Aripiprazole35$559
Gabapentin37$492
Quetiapine Fumarate33$421
Buspirone Hcl34$389
Alprazolam50$354
Sertraline Hcl36$334
Escitalopram Oxalate38$320
Bupropion Hcl SrBupropion Hcl14$301
Trazodone Hcl37$273

Paid to pharmacies, not to this prescriber.

Other psychiatry in Chelsea

See the full list for Michigan

Where these figures come from

Is this you, or does something look wrong? →